Singapore-based Esco Lifesciences Group has announced the acquisition of Allwin Medical Devices, Inc., a leading manufacturer of ART/IVF consumables in the US.

新加坡Esco生命科学集团宣布收购美国领先的ART/IVF耗材制造商Allwin Medical Devices, Inc.

Allwin Medical will continue to operate under its established brand and will become a key pillar within Esco's Medical portfolio, alongside Esco Medical, further strengthening Esco's global position in reproductive medicine.

Allwin Medical 将继续在其原有品牌下运营，并将成为 Esco 医疗产品组合中的重要支柱，与 Esco Medical 齐头并进，进一步巩固 Esco 在生殖医学领域的全球地位。

The acquisition reinforces Esco's strategy and commitment to deliver integrated ART/IVF workflow solutions, combining advanced equipment, time lapse imaging, high-quality consumables, digital traceability and witnessing, and AI-enabled embryo assessment and clinical support into a unified platform for fertility clinics worldwide..

此次收购加强了Esco的战略和承诺，即提供集成的ART/IVF工作流程解决方案，将先进设备、延时成像、高质量耗材、数字可追溯性和见证，以及人工智能赋能的胚胎评估和临床支持整合到一个统一的平台中，为全球的生育诊所服务。

Allwin Medical's operations and team will continue to play a central role in driving growth within Esco's Medical business unit. Headquartered in Anaheim, California, USA,and with Indian operation in Mumbai and Surat, Allwin Medical will serve as a key operating node and the India headquarters for Esco's Medical business unit, supporting further expansion in one of the world's fastest-growing healthcare markets..

Allwin Medical的运营和团队将继续在推动Esco医疗业务部门的增长中发挥核心作用。Allwin Medical总部位于美国加利福尼亚州阿纳海姆，在印度的孟买和苏拉特设有运营机构，它将成为Esco医疗业务部门的关键运营节点及印度总部，支持其在全球增长最快的医疗市场之一的进一步扩展。